Canada’s complicated drug-approval system needs overhaul, former regulator says

Doug Clark knows how long it takes drugs to be approved in Canada, because he’s seen the system from the inside. For a decade up until 2023, Mr. Clark was executive director of Canada’s drug price regulator, the Patented Medicine Prices Review Board (PMPRB). He often bore the brunt of complaints…